Thursday 13 June 2019

The Brewery, London EC1

News:

2013 Shortlist

1. Best Communication Award

Sponsored by M:Communications

  • Ablynx NV
  • Evotec AG
  • Galapagos NV
  • Genmab A/S
  • Oxford BioMedica plc

2. Breakthrough of the Year Award

Sponsored by Canaccord Genuity

  • Ablynx NV
  • Lombard Medical Technologies plc
  • ThromboGenics NV
  • uniQure BV
  • Vectura Group plc

3. Best Technology Award

Sponsored by Design Portfolio

  • Ablynx NV
  • Cosmo Pharmaceuticals SPA
  • Epigenomics AG
  • Oxford BioMedica plc
  • Vectura Group plc

4. Mediscience Commentator of the Year

Sponsored by College Hill

  • Julie Simmonds – Canaccord Genuity
  • The Team at Kempen & Co.
  • Daniel Mahoney – Polar Capital
  • The Team at Scrip
  • Andrew Clark – The Times

5. Transacton of the Year Award

Sponsored by Life Sciences Partners

  • Abcam plc
  • Basilea Pharmaceutica Ltd
  • Clinigen Group plc
  • OctoPlus NV
  • Proximagen Group plc

6. Most Significant Contribution to the Mediscience Sector

Sponsored by Shore Capital

  • David Evans – EKF Diagnostics Holdings plc
  • Prof. Désiré Collen – ThromboGenics NV
  • Dr. Rudi Pauwels – Biocartis NV
  • IP Group plc and Imperial Innovations Group plc
  • Rudy Dekeyser - VIB

7. Chief Executive of the Year Award

Sponsored by Buchanan

  • Dr Patrik De Haes – ThromboGenics NV
  • Geoffrey McDonough – Swedish Orphan Biovitrum AB (SOBI)
  • Ian Page – Dechra Pharmaceuticals plc
  • Prof. Jan van de Winkel – Genmab A/S
  • James Barder – Futura Medical plc

9. Emerging Star of the Year Award

Sponsored by Peel Hunt

  • Biocartis SA
  • Clinigen Group plc
  • Curetis AG
  • Oxford Gene Technology Ltd
  • Symphogen A/S

10. Company of the Year Award

Sponsored by Nomura Code

  • Abcam plc
  • Coloplast Group
  • MorphoSys AG
  • Qiagen NV
  • ThromboGenics NV